{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:18:45Z","timestamp":1782602325929,"version":"3.54.5"},"reference-count":34,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T00:00:00Z","timestamp":1236038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:p>\n                    <jats:bold>Summary.\u2002<\/jats:bold>\n                    Liver diseases associated with hepatitis C virus (HCV) infection have become the major cause of mortality in patients with human immunodeficiency virus (HIV) infection since the introduction of highly active anti\u2010retroviral therapy. HCV\u2010related liver disease is more severe in HIV\u2010infected patients than in non\u2010HIV\u2010infected patients, but the standard therapies used to treat chronic hepatitis C in HCV\/HIV coinfected patients are the same as those for patients infected with HCV alone. HIV protease inhibitors might have potential to down\u2010regulate HCV load of HCV\/HIV coinfected patients. In this study, we evaluated the effects of nelfinavir on intracellular HCV replication using the HCV replicon system. We constructed an HCV replicon expressing a neomycin\u2010selectable chimeric firefly luciferase reporter protein. Cytotoxicity and apoptosis induced by nelfinavir were assessed and synergism between nelfinavir and interferon (IFN) was calculated using CalcuSyn analysis. Nelfinavir dose\u2010dependently repressed HCV replication at low concentrations (IC\n                    <jats:sub>50<\/jats:sub>\n                    , 9.88\u2003\u03bcmol\/L). Nelfinavir failed to induce cytotoxicity or apoptosis at concentrations that inhibited HCV replication. Clinical concentrations of nelfinavir (5\u2003\u03bcmol\/L) combined with IFN showed synergistic inhibition of HCV replication in our replicon model. Our results suggest that the direct effects of nelfinavir on the HCV subgenome and its synergism with IFN could improve clinical responses to IFN therapy in HCV\/HIV coinfected patients.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2893.2009.01102.x","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T01:43:15Z","timestamp":1236044595000},"page":"506-512","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon\u2010\u03b1"],"prefix":"10.1111","volume":"16","author":[{"given":"S.","family":"Toma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Shiroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Maeshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hibiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tateyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,10]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890330307"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/339042"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.01.022"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/323009"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01344.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300409"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/317644"},{"issue":"5","key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00042560-200104150-00011","article-title":"Relation between HIV\u20101 and hepatitis C viral load in patients with hemophilia","volume":"26","author":"Daar ES","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/323665"},{"issue":"10","key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/jcm.31.10.2679-2682.1993","article-title":"Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections","volume":"31","author":"Sherman KE","year":"1993","journal-title":"J Clin Microbiol"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20119"},{"issue":"13","key":"e_1_2_7_13_2","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood.V96.13.4293","article-title":"Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy","volume":"96","author":"Yokozaki S","year":"2000","journal-title":"Blood"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/315143"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.3.1940-1950.2003"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2006.00816.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.2203"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/341084"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332303"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200012220-00011"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199817000-00010"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00162-X"},{"issue":"10","key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1096\/fasebj.5.10.1712326","article-title":"Targeted therapy of human immunodeficiency virus\u2010related disease","volume":"5","author":"Mitsuya H","year":"1991","journal-title":"FASEB J"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-007-0755-3"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00703-1"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3905-3911.2004"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.18.8516-8523.2001"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.embor840"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1842-x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/382595"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4936"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.12.7648-7657.2005"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01411-06"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.020073"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905070-00025"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2009.01102.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.2009.01102.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:29:52Z","timestamp":1697059792000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2009.01102.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,10]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1365-2893.2009.01102.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2009.01102.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1160176.620468","asserted-by":"object"}]},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,10]]}}}